Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kornowski

Showing results (781-790 of 849) with videos related to

Pageof 85
Sort By:
European Heart Journal. Cardiovascular Pharmacotherapy|July 14, 2025
Single versus Dual Antiplatelet Therapy in Patients with Severe Peripheral Arterial Disease Undergoing TAVI: Insights from The Hostile RegistryMattia Galli, Roberto Nerla, Fausto Castriota, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|January 3, 2021
Predictors of high residual gradient after transcatheter aortic valve replacement in bicuspid aortic valve stenosisGiulia Bugani, Matteo Pagnesi, Didier Tchetchè, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|March 24, 2022
Ticagrelor monotherapy after PCI in patients with concomitant diabetes mellitus and chronic kidney disease: TWILIGHT DM-CKDPayam Dehghani, Davide Cao, Usman Baber, et al.
The New England Journal of Medicine|August 27, 2021
Dual Antiplatelet Therapy after PCI in Patients at High Bleeding RiskMarco Valgimigli, Enrico Frigoli, Dik Heg, et al.
American Heart Journal|January 31, 2025
Characterizing high-risk enrollment criteria and impact on clinical outcomes in a large randomized clinical trial: Insights from the TWILIGHT trialPhilippe Gabriel Steg, Johny Nicolas, Usman Baber, et al.
Journal of the American College of Cardiology|August 17, 2023
Bleeding and Ischemic Risks of Ticagrelor Monotherapy After Coronary InterventionsGuiomar Mendieta, Shamir Mehta, Usman Baber, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|August 18, 2022
Ticagrelor with and without aspirin in patients with a prior coronary artery bypass graft undergoing percutaneous coronary intervention: the TWILIGHT-CABG studyGennaro Sardella, Frans J Beerkens, George Dangas, et al.
The Canadian Journal of Cardiology|June 17, 2019
Transcatheter Aortic Valve Replacement Outcomes in Patients With Native vs Transplanted Kidneys: Data From an International Multicenter RegistryGuy Witberg, Jasmin Shamekhi, Nicolas M Van Mieghem, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|July 30, 2025
The Impact of THV Platforms on Transfemoral TAVR in Complex Vascular Access: Insights From the Hostile RegistryChiara Fraccaro, Tullio Palmerini, Giulia Lorenzoni, et al.
JACC. Cardiovascular Interventions|October 25, 2023
Dyspnea-Related Ticagrelor Discontinuation After Percutaneous Coronary InterventionDominick J Angiolillo, Davide Cao, Samantha Sartori, et al.
Pageof 85

Showing results (781-790 of 849) with videos related to

Sort By:
Pageof 85
European Heart Journal. Cardiovascular Pharmacotherapy|July 14, 2025
Single versus Dual Antiplatelet Therapy in Patients with Severe Peripheral Arterial Disease Undergoing TAVI: Insights from The Hostile RegistryMattia Galli, Roberto Nerla, Fausto Castriota, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|January 3, 2021
Predictors of high residual gradient after transcatheter aortic valve replacement in bicuspid aortic valve stenosisGiulia Bugani, Matteo Pagnesi, Didier Tchetchè, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|March 24, 2022
Ticagrelor monotherapy after PCI in patients with concomitant diabetes mellitus and chronic kidney disease: TWILIGHT DM-CKDPayam Dehghani, Davide Cao, Usman Baber, et al.
The New England Journal of Medicine|August 27, 2021
Dual Antiplatelet Therapy after PCI in Patients at High Bleeding RiskMarco Valgimigli, Enrico Frigoli, Dik Heg, et al.
American Heart Journal|January 31, 2025
Characterizing high-risk enrollment criteria and impact on clinical outcomes in a large randomized clinical trial: Insights from the TWILIGHT trialPhilippe Gabriel Steg, Johny Nicolas, Usman Baber, et al.
Journal of the American College of Cardiology|August 17, 2023
Bleeding and Ischemic Risks of Ticagrelor Monotherapy After Coronary InterventionsGuiomar Mendieta, Shamir Mehta, Usman Baber, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|August 18, 2022
Ticagrelor with and without aspirin in patients with a prior coronary artery bypass graft undergoing percutaneous coronary intervention: the TWILIGHT-CABG studyGennaro Sardella, Frans J Beerkens, George Dangas, et al.
The Canadian Journal of Cardiology|June 17, 2019
Transcatheter Aortic Valve Replacement Outcomes in Patients With Native vs Transplanted Kidneys: Data From an International Multicenter RegistryGuy Witberg, Jasmin Shamekhi, Nicolas M Van Mieghem, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|July 30, 2025
The Impact of THV Platforms on Transfemoral TAVR in Complex Vascular Access: Insights From the Hostile RegistryChiara Fraccaro, Tullio Palmerini, Giulia Lorenzoni, et al.
JACC. Cardiovascular Interventions|October 25, 2023
Dyspnea-Related Ticagrelor Discontinuation After Percutaneous Coronary InterventionDominick J Angiolillo, Davide Cao, Samantha Sartori, et al.
Pageof 85